EGFR BsAb (Fuhong)

N/A

Report date: 2025/04/03 15:09:05

Base Information

Drug NameEGFR BsAb (Fuhong)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesShanghai Fuhong Biomedical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fuhong Biomedical Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A